{"nct_id":"NCT00615524","title":"Phase II Study Evaluating Exemestane Alone Or In Combination With Pazopanib In Postmenopausal Women With Hormone Receptor Positive Breast Cancer","status":"WITHDRAWN","status_verified_date":"2018-01","start_date":"2008-04","start_date_type":null,"primary_completion_date":"2012-11","primary_completion_date_type":"ESTIMATED","completion_date":"2012-11","completion_date_type":"ESTIMATED","phases":["PHASE2"],"tickers":["GSK"]}